ArticleCancers2022

Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib.

Bahil Ghanim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.